Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes.

The article focuses on the revised recommendations of the American Diabetes Association (ADA), American Heart Association (AHA) and the American College of Cardiology Foundation (ACCF) on aspirin therapy as a prevention strategy in people with diabetes at increased cardiovascular risk. It references findings from related studies and clinical trials. It outlines the questions considered by a group of experts convened to review and summarize the available evidence.